Description
Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease
Article: Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease
€3.03
Related products
-
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart
Reviews
There are no reviews yet.